Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

Similar articles for PubMed (Select 12181569)

1.

Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria.

Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH.

Nature. 2002 Aug 15;418(6899):785-9.

PMID:
12181569
2.

Synthetic GPI array to study antitoxic malaria response.

Kamena F, Tamborrini M, Liu X, Kwon YU, Thompson F, Pluschke G, Seeberger PH.

Nat Chem Biol. 2008 Apr;4(4):238-40. doi: 10.1038/nchembio.75. Epub 2008 Mar 2.

PMID:
18311131
3.

GPIs on a chip.

Ferguson MA.

Nat Chem Biol. 2008 Apr;4(4):223-4. doi: 10.1038/nchembio0408-223. No abstract available.

PMID:
18347586
4.

Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria.

Perraut R, Diatta B, Marrama L, Garraud O, Jambou R, Longacre S, Krishnegowda G, Dieye A, Gowda DC.

Microbes Infect. 2005 Apr;7(4):682-7. Epub 2005 Mar 21.

PMID:
15848275
5.

Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

Patarroyo ME, Patarroyo MA.

Acc Chem Res. 2008 Mar;41(3):377-86. doi: 10.1021/ar700120t. Epub 2008 Feb 12. Review.

PMID:
18266328
6.

Glycosylphosphatidylinositols in malaria pathogenesis and immunity: potential for therapeutic inhibition and vaccination.

Boutlis CS, Riley EM, Anstey NM, de Souza JB.

Curr Top Microbiol Immunol. 2005;297:145-85. Review.

PMID:
16265905
7.

Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis.

Naik RS, Branch OH, Woods AS, Vijaykumar M, Perkins DJ, Nahlen BL, Lal AA, Cotter RJ, Costello CE, Ockenhouse CF, Davidson EA, Gowda DC.

J Exp Med. 2000 Dec 4;192(11):1563-76.

8.

Neutralization of malaria glycosylphosphatidylinositol in vitro by serum IgG from malaria-exposed individuals.

de Souza JB, Runglall M, Corran PH, Okell LC, Kumar S, Gowda DC, Couper KN, Riley EM.

Infect Immun. 2010 Sep;78(9):3920-9. doi: 10.1128/IAI.00359-10. Epub 2010 Jun 21.

9.

Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum.

Channe Gowda D.

Microbes Infect. 2002 Jul;4(9):983-90. Review.

PMID:
12106792
10.

Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

Ophorst OJ, Radosević K, Ouwehand K, van Beem W, Mintardjo R, Sijtsma J, Kaspers J, Companjen A, Holterman L, Goudsmit J, Havenga MJ.

Vaccine. 2007 Feb 9;25(8):1426-36. Epub 2006 Nov 7.

PMID:
17161889
11.

Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model.

Lu Z, Serghides L, Patel SN, Degousee N, Rubin BB, Krishnegowda G, Gowda DC, Karin M, Kain KC.

J Immunol. 2006 Nov 1;177(9):6344-52.

12.

Plasmodium falciparum glycosylphosphatidylinositol toxin interacts with the membrane of non-parasitized red blood cells: a putative mechanism contributing to malaria anemia.

Brattig NW, Kowalsky K, Liu X, Burchard GD, Kamena F, Seeberger PH.

Microbes Infect. 2008 Jul;10(8):885-91. doi: 10.1016/j.micinf.2008.05.002. Epub 2008 May 14.

PMID:
18657459
14.

A convergent, versatile route to two synthetic conjugate anti-toxin malaria vaccines.

Seeberger PH, Soucy RL, Kwon YU, Snyder DA, Kanemitsu T.

Chem Commun (Camb). 2004 Aug 7;(15):1706-7. Epub 2004 Jul 9.

PMID:
15278147
15.

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230.

Fanning SL, Czesny B, Sedegah M, Carucci DJ, van Gemert GJ, Eling W, Williamson KC.

Vaccine. 2003 Jul 4;21(23):3228-35.

PMID:
12804852
16.

Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1).

Nair M, Hinds MG, Coley AM, Hodder AN, Foley M, Anders RF, Norton RS.

J Mol Biol. 2002 Sep 27;322(4):741-53.

PMID:
12270711
17.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.

Lalitha PV, Biswas S, Pillai CR, Saxena RK.

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

PMID:
18590786
18.

Synthesis of a malaria candidate glycosylphosphatidylinositol (GPI) structure: a strategy for fully inositol acylated and phosphorylated GPIs.

Lu J, Jayaprakash KN, Schlueter U, Fraser-Reid B.

J Am Chem Soc. 2004 Jun 23;126(24):7540-7.

PMID:
15198601
19.

In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.

Miura K, Zhou H, Muratova OV, Orcutt AC, Giersing B, Miller LH, Long CA.

Infect Immun. 2007 Dec;75(12):5827-36. Epub 2007 Oct 8.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk